Skip to Content

Rule

Medical Devices; Reports of Corrections and Removals; Technical Amendment

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule; technical amendment.

SUMMARY:

The Food and Drug Administration (FDA) is amending its regulation regarding reports of corrections to and removals of medical devices to address a minor change as a result of the enactment of the Food and Drug Administration Amendments Act of 2007 (FDAAA). This action is technical in nature and is intended to provide accuracy to the Agency's regulation.

DATES:

This rule is effective February 19, 2014.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Deborah Yoder, Office of Compliance, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 2676, Silver Spring, MD 20993-0002, 301-796-6109, Deborah.Yoder@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Section 806.1(a) (21 CFR 806.1(a)) refers to a subsection of the Federal Food, Drug, and Cosmetic Act that was redesignated as a result of FDAAA (Pub. L. 110-85). FDA is amending § 806.1(a) to update the obsolete reference.

FDA is publishing the document as a final rule under the Administrative Procedures Act (5 U.S.C. 551, et seq.). FDA has determined that good cause exists to dispense with prior notice and public comment under 5 U.S.C. 553(b)(3)(B) and 21 CFR 10.40(e)(1) since such notice and comment are unnecessary because this amendment to the regulation provides only a technical change to update an obsolete citation. In addition, FDA finds good cause to provide for this regulation to be effective immediately upon publication under 5 U.S.C. 553(d)(3).

FDA has determined under 21 CFR 25.30(i) that this final rule is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.

This final rule contains information collection provisions that are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The collections of information in 21 CFR part 806 have been approved under OMB control number 0910-0359, which expires May 31, 2014.

Start List of Subjects

List of Subjects in 21 CFR Part 806

  • Imports
  • Medical devices
  • Reporting and recordkeeping requirements
End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 806 is amended as follows:

Start Part

PART 806—MEDICAL DEVICES; REPORTS OF CORRECTIONS AND REMOVALS

End Part Start Amendment Part

1. The authority citation for 21 CFR part 806 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 352, 360, 360i, 360j, 371, 374.

End Authority
[Amended]
Start Amendment Part

2. Amend § 806.1(a) by removing “section 519(f)” and adding in its place “section 519(g)”.

End Amendment Part Start Signature

Dated: February 12, 2014.

Leslie Kux,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2014-03581 Filed 2-18-14; 8:45 am]

BILLING CODE 4160-01-P